Current research suggests that a reduction in breast cancer screenings at the beginning of the COVID-19 pandemic may have contributed to fewer early-stage and more late-stage breast cancer diagnoses in 2020 (latest statistics available) than in 2019, according to a study published by the journal JAMA Network Open.3

Many people experienced delayed or cancelled mammograms because of the pandemic, and these disruptions may have contributed to later-stage breast cancer diagnoses, when the disease is more difficult to treat.3,4

While mammography screenings rebounded overall by July 2020, the cumulative deficit of missed mammograms may have important public health consequences,5 including the furthering of health disparities.6

Since 2021, breast cancer diagnoses have exceeded lung cancer diagnoses, becoming the most diagnosed cancer worldwide.7,8

In the United States, it is estimated that about 287,850 women in 2022 will be diagnosed with breast cancer.9 Breast cancer is the most commonly diagnosed cancer among women in the U.S., and this year it’s estimated that about 30% of all newly diagnosed cancers in women will be breast cancers.10

For those facing a breast cancer diagnosis, the treatment that follows can be challenging and time consuming. Additionally, the type of breast cancer a patient has — including triple negative, HER2+ or HR+ — impacts the type of treatment they’ll receive.

Dr. Ahmed Elkhanany, a breast cancer expert at the University of Alabama at Birmingham, will discuss the latest news surrounding delays in breast cancer screenings and some of the recent treatment options. A patient share her experience too.

Interview courtesy: Genentech

1 American Cancer Society. American Cancer Society Recommendations for the Early Detection of Breast Cancer. https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html. Accessed June 9, 2022.
2 American Cancer Society. Survival Rates for Breast Cancer. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html. Accessed June 9, 2022.
3 Zhou J, et al. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic. JAMA Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789064. Accessed June 1, 2022.
4 Elek P, et al. Effects of lower screening activity during the COVID-19 pandemic on breast cancer patient pathways: Evidence from the age cut-off of organized screening. Health Policy. https://www.sciencedirect.com/science/article/pii/S0168851022001257?via%3Dihub. Accessed June 9, 2022.
5 Sprague B, et al. Changes in Mammography Utilization by Women’s Characteristics during the First 5 Months of the COVID- 19 Pandemic. JNCI. 29 March 2021. https://academic.oup.com/jnci/advance-article/doi/10.1093/jnci/djab045/6184869.
Accessed June 1, 2022.
6 DeGroff A, et al. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States. Preventive Medicine. 2021. https://www.sciencedirect.com/science/article/pii/S0091743521001432?utm_campaign=11a0a4d458MR_COPY_02&utm_medium=email&utm_source=STAT+Newsletters&utm_term=0_8cab1d7961-11a0a4d458-153427414. Accessed June 1, 2022.
7 World Health Organization. Breast cancer now most common form of cancer: WHO taking action. https://www.who.int/news/item/03-02-2021-breast-cancer-now-most-common-form-of-cancer-who-taking-action. Accessed June 1, 2022.
8 International Agency for Research on Cancer. All-cancers fact-sheet. https://gco.iarc.fr/today/fact-sheets-cancers. Accessed June 10, 2022.
9 National Cancer Institute, The Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts: Female Breast Cancer. https://seer.cancer.gov/statfacts/html/breast.html. Accessed June 10, 2022.
10 BreastCancer.org. U.S Breast Cancer Statistics. https://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed June 10, 2022.

#breastcancer #ahmedelkhanany #pandemic #melissa #women #survivalrates #covid #delayed #cancelmammograms #cancelledmammograms #disruptions #genentech #screening #treatment #experience

The post DROP IN EARLY BREAST CANCER DIAGNOSES TIED TO PANDEMIC appeared first on Good News!.

Non-small cell lung cancer (NSCLC) is the most common form, accounting for approximately 85% of all lung cancers.2 Many people diagnosed with early-stage NSCLC have surgery to remove the cancer; however, for approximately half of these patients, the cancer unfortunately returns.3 Experts agree there is an urgent need for enhanced screening uptake — which has hovered around five percent in recent years amongst those eligible to receive it4 — as well as improved treatment options in early-stage NSCLC to help prevent devastating cancer recurrences.

Studies have shown that treatments beyond chemotherapy, including targeted therapy and now immunotherapy – a type of personalized cancer treatment that activates the immune system to fight cancer – may help improve outcomes for certain patients with early-stage NSCLC after surgery.5 What’s promising is that these studies have now led to U.S. Food and Drug Administration approvals in the post-surgery setting to help reduce the risk of recurrence for patients with specific types of early-stage NSCLC, introducing a new era for these lung cancer patients.

Dr. David Carbone, Professor of Internal Medicine and Director of the James Thoracic Oncology Center at Ohio State University Medical Center will discuss the latest progress, including one of the most recent developments in early-stage lung cancer for patients.

Interview courtesy: Genentech

1 ACS. Key Statistics for Lung Cancer. 2022. Accessed from: https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html.
2 Molina et al. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clin Proc. 2008 May; 83(5): 584–594. Accessed September 27, 2021.
3 Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin
Oncol. 2014;5(5):1048-1054. doi:10.5306/wjco.v5.i5.1048
4 Fedewa SA, Kazerooni EA, Studts JL, et al. State Variation in Low-Dose CT Scanning for Lung Cancer Screening in the United States. JNCI: The Journal of the National Cancer Institute. doi: 10.1093/jnci/djaa170
5 Zappa et al. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016 Jun; 5(3): 288–300. doi:
10.21037/tlcr.2016.06.07.

#davidcarbone #lungcancer #genentech #americancancersociety #factsfigures #disease #aminotherapy #etizolam #go2foundation #nsclc #surgery #chemotherapy #medicine #treatments #patients

The post EXCITING PROGRESS IN DIAGNOSING AND TREATING EARLY-STAGE LUNG CANCER appeared first on Good News!.

STORIES OF INSPIRATION
During Holiday Season
https://www.hemlibra.com/

In recent years, people with hemophilia A have found hope thanks to important developments in the treatment of this bleeding disorder. For some living with this chronic condition, this may mean experiencing the coming holiday season with a new outlook on living with hemophilia A.

Guy is in his mid-30’s and was diagnosed with hemophilia A at birth. As a child, he experienced spontaneous brain bleeds at 18-months-old and again at three-years-old, which led to him becoming legally blind and experiencing seizures. Guy remembers going to the hospital multiple times a week for treatment and having over 20 surgeries. As a young adult, he avoided certain activities that might lead to a bleed.

Hemophilia A is a rare genetic bleeding disorder, typically diagnosed at a very young age, in which a person’s blood does not clot properly, leading to uncontrolled bleeding that can occur spontaneously. There are approximately 20,000 people who have hemophilia in the United States, with hemophilia A being the most common form.1,2 For people diagnosed with this rare condition, it can be a life-altering diagnosis. Even with treatment, hemophilia A can result in bleeds in muscles and joints that may lead to joint damage and chronic pain.2

People like Guy can face significant challenges managing their condition.3 After decades of accepting this as his normal, he began a different medicine that he takes once a month and has experienced fewer bleeds requiring treatment. Guy recently earned a master’s degree to pursue a career in strategic marketing. He has so much to celebrate this holiday season–it will be particularly special as his first as a newlywed after getting married in a small ceremony this past June.

Dr. Amy Shapiro, a hematologist-oncologist and Co-Founder of the Indiana Hemophilia and Thrombosis Center along with Guy Law, to discuss the impact this latest treatment continues to have for people living with hemophilia A.

Interview is courtesy: Genentech

1 Hemophilia Federation of America. Hemophilia A. https://www.hemophiliafed.org/understanding-bleeding-disorders/what-ishemophilia/hemophilia-a. Accessed October 12, 2020.
2 Mayo Clinic. Symptoms and Causes. https://www.mayoclinic.org/diseases-conditions/hemophilia/symptoms-causes/syc20373327. Accessed October 12, 2020.
3 Bauer, K. A. (2015). Current Challenges in the Management of Hemophilia. American Journal of Managed Care, 21(6).

#hemophilia #hemlibra #amy #shapiro #indiana #thrombosis #guy #law #hope #inspiration #holiday #season #bleeding #blood #disorder #chronic #condition #diagnosed #seizures #hospital #muscles #pain #oncologist #treatment #marketing #genentech #america

The post Hope for Those with Hemophilia appeared first on Good News!.